Lifeway Foods, Inc. issued a statement on March 4, 2025, regarding what it termed 'predatory actions' by Danone, including a lawsuit referenced in Danone's latest Schedule 13D filing. Lifeway characterized Danone's campaign as an attempt to execute a hostile takeover at an undervalued price.
Lifeway stated its intention to file a counterclaim against Danone and aggressively contest its claims, asserting that the 1999 Stockholders' Agreement, which Danone has allegedly leveraged, is invalid. The company believes Danone has exploited this agreement to its own benefit at the expense of Lifeway shareholders.
Despite the legal dispute, Lifeway highlighted its strong financial performance, reporting that its full-year unaudited 2024 results represent a record year in top-line revenue, net income, and EBITDA. Additionally, gross sales for the last week of February 2025 increased by 17% year-over-year to $4,543,297.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.